Celltech Pharma Europe Limited
Records under this name other than patents Celltech Pharma Europe Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Celltech Pharma Europe Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,280,410 | Method of filling a drug capsule and article produced thereby Formerly held Term ended Term ended Oct 2, 2018 · From the USPTO record | Term ended | Term ended Oct 2, 2018 | From the USPTO record |
| US 6,113,879 | Composition comprising methylphenidate and another drug Term ended Term ended Jun 29, 2018 · From the USPTO record | Term ended | Term ended Jun 29, 2018 | From the USPTO record |
| US 6,554,818 | Method of filling a drug capsule and article produced thereby Formerly held Term ended Ended no later than Mar 27, 2017 · From the USPTO record | Term ended | Ended no later than Mar 27, 2017 | From the USPTO record |
| US 7,267,949 | Composition comprising methylphenidate and another drug Lapsed on the fee record Ended Sep 11, 2015 · From the USPTO record | Lapsed on the fee record | Ended Sep 11, 2015 | From the USPTO record |
| US 6,468,504 | Composition comprising methylphenidate and another drug Lapsed on the fee record Ended Oct 22, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2014 | From the USPTO record |
| US 6,162,433 | Non antibiotic selectable markers for live vaccines Lapsed on the fee record Ended Dec 19, 2012 · From the USPTO record | Lapsed on the fee record | Ended Dec 19, 2012 | From the USPTO record |
| US 6,121,453 | Resolution of threo-methylphenidate Lapsed on the fee record Ended Sep 19, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 19, 2012 | From the USPTO record |
| US 7,384,959 | Treatment of convulsive states Lapsed on the fee record Ended Jun 10, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jun 10, 2012 | From the USPTO record |
| US 6,531,489 | Single isomer methylphenidate and resolution process Lapsed on the fee record Ended Mar 11, 2011 · From the USPTO record | Lapsed on the fee record | Ended Mar 11, 2011 | From the USPTO record |
| US 7,164,025 | Manufacture of single isomer methylphenidate Lapsed on the fee record Ended Jan 16, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jan 16, 2011 | From the USPTO record |